FdaApplication

NDA 214070

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTRAZENECA PHARMACEUTICALS LP
application_typeNDA
approval_date2023-01-10

Products (1)

ProductActive ingredientStrengthDosage form
AIRSUPRAALBUTEROL SULFATE; BUDESONIDEEQ 0.09MG BASE/INH;0.08MG/INHAEROSOL, METERED;INHALATION

1 product